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Members of the fibroblast growth factor (FGF) family have myriad functions during
development of both non-vertebrate and vertebrate organisms. One of these family
members, FGF10, is largely expressed in mesenchymal tissues and is essential for
postnatal life because of its critical role in development of the craniofacial complex, as
well as in lung branching. Here, we review the function of FGF10 in morphogenesis of
craniofacial organs. Genetic mouse models have demonstrated that the dysregulation
or absence of FGF10 function affects the process of palate closure, and FGF10 is
also required for development of salivary and lacrimal glands, the inner ear, eye lids,
tongue taste papillae, teeth, and skull bones. Importantly, mutations within the FGF10
locus have been described in connection with craniofacial malformations in humans.
A detailed understanding of craniofacial defects caused by dysregulation of FGF10 and
the precise mechanisms that underlie them offers new opportunities for development of
medical treatments for patients with birth defects and for regenerative approaches for
cancer patients with damaged gland tissues.
Keywords: FGF10, craniofacial development, palate, salivary gland, lacrimal gland, inner ear, eyelid, taste papillae
INTRODUCTION
FGF10 is a member of the fibroblast growth factor (FGF) family, a highly evolutionarily conserved
group of proteins that trigger signaling via receptor tyrosine kinases. The FGF signaling pathway
plays central roles in developmental processes from head to toe, including formation of the brain,
limbs, kidneys, hair follicles, and body axis elongation (Rosenquist and Martin, 1996; Lewandoski
et al., 2000; Basson et al., 2008; Walker et al., 2016; Oginuma et al., 2017). The FGF family contains
22 ligands grouped into 7 subfamilies, and these ligands can bind to 4 receptors (FGFR1–4) (Ornitz
and Itoh, 2001). The interaction of FGF ligands with their receptors is regulated by the extracellular
environment, through proteoglycan cofactors and extracellular binding proteins. Activation of
FGF receptors involves phosphorylation of specific tyrosine residues that mediate interaction
with cytosolic adaptor proteins and the RAS-MAPK, PI3K-AKT, PLCγ, and STAT intracellular
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signaling pathways (Ornitz and Itoh, 2015). FGF10 is a canonical
FGF and belongs to the FGF7 subfamily, together with FGF3,
FGF7, and FGF22. The common feature of these FGF ligands is
their specific binding of the IIIb splice variant of FGFR 1 and
2 (Zhang et al., 2006). Moreover, during organogenesis FGF10
serves as a major ligand for the FGFR 2 IIIb isoform, which
localizes to the epithelium (Ohuchi et al., 2000), and in general
Fgf10 is predominantly expressed in the mesenchyme, with the
protein it encodes signaling to the epithelium.
The majority of studies on the role of FGF10 in vertebrates
have been performed using mice carrying null mutations in
Fgf10. In addition to the craniofacial complex, many other organs
of the body are affected in the Fgf10 null mutants. Among
the most prominent phenotypes in the mutants are that both
hindlimbs and forelimbs are completely missing (amelia), and
there is lung agenesis (Ohuchi et al., 2000; Figure 1). Perinatal
lethality in the Fgf10 mutants results from respiratory failure.
Notably, the phenotype of Fgfr2 mutant mice almost completely
overlaps with that of Fgf10 mutants (Ohuchi et al., 2000).
Mutations in FGF10 have been found to cause numerous
developmental defects and pathologies in humans. For example,
loss-of-function mutations in FGF10 have been reported to cause
LADD (Lacrimo-auriculo-dento-digital) syndrome (Milunsky
et al., 2006; Shams et al., 2007), which affects multiple organs,
the majority of which are in the craniofacial complex. This and
other human conditions connected to craniofacial development
are further discussed below.
FIGURE 1 | (A,B) Whole-mount µCT images of wild-type and Fgf10 null
mouse embryos at E18.5. (C,D) Medial cross-sections through wild-type and
mutant embryo. Fgf10 mutant embryos show complete amelia; another
pronounced phenotype is lung agenesis (asterisk). B, brain; BF, brown fat; H,
heart; I, intestines; L, lungs; Li, liver; S, stomach; T, tongue.
ROLE OF FGF10 IN CRANIOFACIAL
MORPHOGENESIS
Fgf10 is expressed largely in the mesenchyme of many developing
structures within the craniofacial complex, including teeth,
tongue and palatal shelves, and it signals to epithelia where Fgfr2
is expressed. Mutations in Fgf10 lead to a wide range of defects,
emphasizing the central importance of FGF10 signaling in many
developmental processes.
Palatogenesis
FGF10 is crucial for the process of closure of the secondary palate.
Both Fgf10 (Figures 2C,D) and Fgfr2 null mouse strains exhibit
cleft palate with complete penetrance (Rice et al., 2004). Fgf10
is expressed most strongly between embryonic day (E)11 and
E13 in the mesenchyme of the anterior and middle portion of
the shelves (Rice et al., 2004; Alappat et al., 2005). During this
developmental period, palatal shelf outgrowth occurs prior to the
subsequent elevation and fusion of the shelves between E14 and
E15. At later stages, the Fgf10 mutant shelves are shorter, square
in shape, and missing the finger-like projections that normally
reach each other and fuse (Rice et al., 2004). This change in
morphology can be explained by differences in the regulation of
cell proliferation and apoptosis. While one study reported that
FIGURE 2 | (A–D) Sagittal (A,B) and frontal (C,D) µCT sections of wild-type
and Fgf10 null embryos at E18.5. Absence of submandibular salivary gland
(structure marked by arrowhead in wild-type in panels A,C) and cleft palate
phenotype (asterisk in panel D) can be observed in Fgf10 null embryos. E,
eye; LM, lower molar; P, palate; T, tongue; S, salivary gland; UM, upper molar.
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there are no apparent differences in the overall proliferation of the
shelves (Alappat et al., 2005), another suggested that proliferation
of epithelial cells is decreased in the FGF10 deficient palatal
shelves along with downregulation of the morphogen encoded
by Shh (Rice et al., 2004). Both studies then showed a significant
increase in apoptosis mainly in the medial edge epithelium of
the developing shelves (Rice et al., 2004; Alappat et al., 2005).
Despite the discrepancies, it appears that FGF10 signals from the
palatal mesenchyme to the epithelium and affects the cell fate and
subsequently the outgrowth and shape of the palatal shelves.
Besides cell proliferation and survival, another mechanism
possibly contributing to the formation of cleft palate in Fgf10
mutants is the presence of aberrant adhesions of the epithelium
of the shelves with the epithelium of the tongue or with other
parts of the oral epithelium (Rice et al., 2004; Alappat et al., 2005).
Presence of these fusions likely prevents the horizontalization
(elevation) process of the palatal shelves, so they are kept in
a vertical position and cannot begin to reach each other. Of
note, when the tissue explants of the palatal shelves of Fgfr2−/−
mice were isolated and cultured in vitro in close proximity, the
epithelia fused normally (Rice et al., 2004). The molecular basis
behind the tendency to form aberrant epithelial fusions may be
related to the regulation of Notch signaling by FGF10. Mutations
in the Notch ligand Jagged2 cause cleft palate with unelevated
shelves heavily fused to the tongue epithelium (Jiang et al., 1998),
and the Fgf10 mutants exhibit severe downregulation of Jagged2
expression within the palatal shelf epithelium at E12.5 (Alappat
et al., 2005). This suggests that FGF10 is upstream of Notch
signaling in the developing palatal shelves and affects the ability
and correct timing of their fusion potential.
Tongue morphology is also altered in the Fgf10 mutants.
Likely due to the presence of aberrant epithelial fusions, the
tongue does not descend as it should, which perturbs this
necessary step in the process of shelf elevation (Rice et al., 2004).
Indeed, a partial ankylosis of the tongue (adherence to the floor
of mouth accompanied by immobility) is present in the Fgf10
mutant embryos (Rice et al., 2004). Notably, overexpression of
Fgf10 also affects the tongue shape and can lead to cleft palate.
This phenomenon was described in mice with neural crest-
specific Tak1 deletion, which affects TGFβ signaling, in turn
leading to activation of FGF10, higher cell proliferation, and
significantly increased height of the tongue that prevents the
elevation of palatal shelves (Song et al., 2013). The role of TGFβ
signaling upstream of FGF10 in morphogenesis of the tongue was
also confirmed when Tgfbr2 was conditionally deleted in neural
crest cell progeny, as the addition of endogenous FGF10 rescued
the muscle cell number in mutant tongues (Hosokawa et al.,
2010). FGF10 also regulates tongue taste papillae development,
which is discussed below.
In humans, genome-wide association studies (GWAS) have
shown that SNPs near FGF10 are highly associated with cleft
lip and/or palate (Shi et al., 2009; Yu et al., 2017). Likely, due
to their different orofacial shape with a more prominent rostral
component, cleft lip does not typically occur spontaneously in
mice, and it is rarely observed even with genetic or environmental
challenge. Therefore, this model organism is theoretically not
an ideal one to study cleft lip etiology. Nevertheless, there are
certain mouse strains that are susceptible to developing cleft lip,
e.g., the group of so-called A strains that exhibit smaller midface
size compared to other strains (Young et al., 2007). Among the
A strains, A/WySn has the highest spontaneous incidence of
cleft lip, ranging between 20 and 30% (Juriloff, 1982). The high
prevalence and susceptibility of these mice to cleft lip is thought
to be caused by a mutation in Wnt9b, which is also on the list
of top clefting genes from human GWAS data (Juriloff et al.,
2006; Yu et al., 2017) Wnt9b knockout mice exhibit cleft lip and,
importantly, the expression of Fgf8, Fgf10, and Fgf17 is down-
regulated in the tissue of facial processes forming the future lip
in these mice. Taken together, the data from GWAS along with
the data from susceptible mouse strains suggest a role for FGF10
in lip development, despite the absence of cleft lip in Fgf10−/−
mice.
Notably, soft palate development is also dependent on FGF10,
and this cannot be evaluated in Fgf10 null mutants, because the
wide hard cleft palate interferes with the later development of
the soft palate. Loss of Dlx5 leads to shortening of the soft palate
and absence of adjacent muscles that are derived from the fourth
pharyngeal arch. Fgf10 was shown to lie downstream of DLX5,
and the Dlx5 mutant phenotype can be rescued by addition of
FGF10 (Sugii et al., 2017).
Eye Lid Development
Another clefting-like pathology in the craniofacial area is the
phenotype of open eyelids in Fgf10 null mice at prenatal stages
when the eye is normally covered by skin (Figures 1B, 3B). The
absence of Fgf10, which is normally expressed in the mesenchyme
beneath the protruding epidermal cells of the nascent eyelid,
causes a decrease in proliferation of these cells as well as changes
in their shape, along with hampering their coordinated migration
(Tao et al., 2005). These effects are due to downstream regulation
of pathways important for these processes, including activin,
TGFα, and SHH (Tao et al., 2005).
Skull Morphology
A major group of human craniosynostosis syndromes, including
Apert, Crouzon, or Pfeiffer syndromes, is caused by mutations
leading to overactivation of Fgf receptors. Apert and Crouzon
syndromes are caused by mutations in FGFR2 that increase
affinity of the receptor for the ligand, and Pfeiffer syndrome
is caused by mutations in either FGFR2 or FGFR1 (Schell
et al., 1995; Anderson et al., 1998; Hibberd et al., 2016). The
search for specific ligands involved in the process of fusion of
the sutures revealed that FGF10 can play a significant role in
proper formation of skull shape. Fgf10 mRNA is present in the
osteoprogenitors in the frontal bone condensation (Veistinen
et al., 2009), and genetic knock-down of Fgf10 rescues the skeletal
phenotype in an Apert syndrome mouse model FgfR2-IIIc+/1
(Hajihosseini et al., 2009). When compared perinatally, the Fgf10
null embryos do not exhibit pathological morphology of calvarial
bones, while the FgfR2-IIIc+/1 mice already lack the coronal
suture (Hajihosseini et al., 2009). Unfortunately, postnatal
development of skull bones and sutures cannot be followed in the
perinatal lethal Fgf10 null mutants, so it is not possible to exclude
that the loss of FGF10 has an impact on skull morphology.
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FIGURE 3 | (A–D) Frontal (A,B) and sagittal (C,D) µCT sections of wild-type
and Fgf10 null embryos at E18.5. Note absence of eyelid (arrowhead in panel
B) and hypoplasia of ocular glands (Harderian and extraorbital lacrimal glands
marked by asterisks in panels A,C, respectively) in Fgf10 null embryos. E, eye;
P, palate; Th, thymus.
Nevertheless, it is instructive to consider the Apert syndrome
model, in which the mice are hemizygous for Fgfr2 IIIC and
exhibit a splicing switch resulting in ectopic expression of FGFR2
IIIb in calvarial mesenchyme; similar mutations are only rarely
found in humans (Hajihosseini et al., 2001, 2009; Bochukova
et al., 2009). More than 98% of Apert syndrome patients
carry either Ser252Trp or Pro253Arg missense gain-of-function
mutations in the IIIa exon (common for IIIb and IIIc variants).
These mutations likely predominantly cause the skull defects
through aberrant function of FGFR2 IIIc, which is involved
in proper bone formation (Eswarakumar et al., 2002). Taken
together, these findings suggest that FGF10 may be dispensable
for the properly timed fusion of sutures and skull development,
but unphysiologically high and/or ectopically activated FGFR2
signaling triggered by FGF10 can cause developmental defects of
these structures.
Sensory Organs
FGF10 also affects the development of organs that possess
a sensory function or will sustain it postnatally, including,
as mentioned above, the taste papillae of the tongue. The
mammalian tongue epithelium contains three types of papillary
structures that house taste cells – the foliate, fungiform, and
circumvallate (CVP) papillae. The multiple fungiform papillae
covering approximately two thirds of the tongue dorsum and
the posteriorly situated CVP have been shown to be regulated
by FGF10 (Petersen et al., 2011; Prochazkova et al., 2017).
Interestingly, the effect of Fgf10 is opposite in these two
types of taste papillae. The CVP, which is normally a single
structure in mouse, is absent or diminished in Fgf10 null
murine tongues, whereas the overactivation of RTK signaling
in embryos carrying mutations in the RTK negative feedback
regulator Sprouty (Spry) genes led to enlargement of the papillary
field and presence of multiple CVPs (Petersen et al., 2011). In
contrast, the development of fungiform papillae is negatively
affected by the level of FGF10, such that the fungiform papillae
of Fgf10−/− tongues are significantly larger, and in Spry2−/−
tongues with increased FGF signaling they are much smaller.
Notably, fungiform size is controlled by FGF10, but the overall
patterning is not; at a mechanistic level, the downstream action
of FGF10 is likely exerted by affecting the diffusion as opposed to
the transcription of Wnt ligands (Prochazkova et al., 2017). The
difference in regulation of papillary area in CVP and fungiform
papillae might result from a different developmental origin of the
part of the tongue covered by fungiform papillae (ectodermal)
versus the posterior part near the root of the tongue housing the
CVP (endodermal) (Rothova et al., 2012). Whether the level of
FGF10 signaling can impact the quality of taste remains an open
question.
Another sensory organ with dysregulated development in
Fgf10 mutant embryos is the inner ear. Absence of FGF10 leads to
complete agenesis of the posterior semicircular canal. In addition,
malformations are present in the anterior and lateral canals as
well as in the positioning of the remaining sensory epithelia with
respect to the utricle; defects were also observed in the cilia of hair
cells (Pauley et al., 2003). Interestingly, heterozygous Fgf10+/−
mice also exhibit reduction or even absence of the posterior
canal, suggesting a strong dependence on FGF10 dosage during
development of this structure (Urness et al., 2015). In addition
to the motion detection part of the inner ear, the Fgf10 mutant
embryos also exhibit pathologies in morphology of cochlear non-
sensory regions, including shorter and narrower duct, absence
of Reissner’s membrane within the cochlear epithelium, and
agenesis of a large portion of the outer sulcus (Urness et al.,
2015). Even though these structures belong to the non-sensory
part of the cochlea, both the Reissner’s membrane and the
outer sulcus are important for maintenance of the endolymph
homeostasis and therefore necessary for hearing. Similar defects
might be present also in humans and explain a part of the
phenotype LADD syndrome caused by mutations in FGF10 or
FGFR2 (Milunsky et al., 2006). More than half of the affected
individuals suffer from hearing loss, and cochlear hypoplasia was
also observed in some of the patients (Lemmerling et al., 1999;
Milunsky et al., 2006). The severity of hearing defects might
be more pronounced when a causative mutation in FGFR2 is
present, as FGF10 has a redundant role with FGF3 during inner
ear formation – the murine double mutants for these FGFs fail
to form otic vesicles (Alvarez et al., 2003; Wright, 2003). Notably,
the FGFR2 IIIb knock-out mice exhibit more severe phenotypes
than single Fgf3 and Fgf10 mutants, but their inner ear is affected
less than in the Fgf3/Fgf10 dKOs (Pirvola et al., 2000; Alvarez
et al., 2003). This discrepancy suggests that FGF3 and FGF10 in
the ear region can possibly also bind other FGF receptors, such
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as FGFR1, which has affinity for these two ligands (Zhang et al.,
2006). The FGFR2 IIIc form may also be activated by FGF3/10,
because the general FGFR2 mutant has a more pronounced
phenotype than FGFR2 IIIb only (Xu et al., 1998; Alvarez et al.,
2003). However, this might be explained by an additional role
of FGF8 during early inner ear development (Domínguez-Frutos
et al., 2009).
Fgf10 is also highly expressed in the external ear (pinna) of
mouse embryos (El Agha et al., 2012) and, interestingly, one
of the defects observed in the LADD patients are low-set, cup-
shaped ears. Nevertheless, no external ear abnormalities have so
far been described in direct connection to FGF10 (see normal
pinna in Fgf10 mutant embryos in Figure 1). It may be again a
case of compensation by another FGF ligand and their common
dysfunction in patients with FGFR2 rather than FGF10 mutations
per se.
Development of Teeth and Mandible
The molar tooth germ is a widely used model for studying
epithelial morphogenesis and epithelial–mesenchymal
interactions. In mouse, tooth development starts at ∼E11.5
with active rearrangement of epithelial cells in the posterior area
of the jaws, where FGF8 serves as a major signaling molecule
(Prochazka et al., 2015). A cylindrical epithelial invagination
called the dental lamina is formed at E12.5, and at E13.5,
progressive budding of epithelium from the dental lamina takes
place, which is supported by condensing neural crest-derived
cells expressing Fgf3 and Fgf10 (Kettunen et al., 2000). The
rapid epithelial ingrowth is accompanied by formation of a
signaling center called the enamel knot. Mesenchymal Fgf10
is expressed in the area of the mandible where future molar
teeth form, and complete agenesis of molars was described in
Fgfr2 deficient mouse embryos, but with the loss of Fgf10 only
minor morphological defects are observed in molar development
(Ohuchi et al., 2000); the absence of a dramatic Fgf10 mutant
tooth phenotype is likely due to compensation by Fgf3. The
budding process of the molar primordia in Fgf10−/− embryos
is delayed around E13, but at later stages tooth development
catches up, and the final molar tooth is only slightly smaller in
size compared to wild-type (Ohuchi et al., 2000; Veistinen et al.,
2009; Figure 2).
In rodents, the incisors are evergrowing, with a population
of adult stem cells present in the most proximal region called
the cervical loop (Harada et al., 1999). Fgf10 plays a major role
in maintenance of the stem cell niche of the mouse incisor by
regulation of Notch signaling in the dental epithelium (Harada
et al., 1999). The Fgf10 null embryo incisor is apparently
smaller, mainly because of an absent cervical loop (Ohuchi et al.,
2000; Harada et al., 2002). Related to this, FGF10 has been
suggested as a principal morphogenetic factor driving the teeth
toward an evergrowing fate, as Fgf10 expression is maintained in
continuously growing teeth (e.g., mouse incisor or vole molar)
throughout life, and the Fgf10 mutant incisors lose continuously
growing features when cultured in kidney capsules (Yokohama-
Tamaki et al., 2006).
One group of pathologies associated with LADD syndrome
are dental defects. The patients often have underdeveloped
teeth with thin enamel and peg-shaped incisors. Even though
molar development does not seem to be severely affected in
the absence of FGF10 when evaluated prenatally in the mouse
model, the findings in LADD patients support the role of FGF10
in tooth development. Some of the LADD patients suffering
from dental pathologies may carry a specific genetic alteration
in FGFR2 (Rohmann et al., 2006; Shams et al., 2007). However,
there are also reports of patients with enamel hypoplasia or
small teeth with disrupted caps and crown morphology that
are associated with FGF10 mutations (Milunsky et al., 2006).
Moreover, increased expression of FGF10 along with FGF7 was
found in samples from human ameloblastoma, a benign jaw
tumor originating from the cells of odontogenic epithelium,
and FGF10 was shown to directly support proliferation of these
cells (Nakao et al., 2013). The mild phenotype and normal cell-
differentiation gradient of ameloblasts and odontoblasts in Fgf10
null embryos (Harada et al., 2002) suggest that human dental
development might differ from that of mice. Because the post-
eruption dentition cannot be studied in the perinatal lethal
Fgf10−/− mice, conditional models will be needed in the future.
Similarly to tooth development, mandibular morphogenesis
is not severely altered in Fgf10 null embryos. Nevertheless, the
developing jaw is apparently sensitive to the dosage of FGF10,
as in the rat model, Fgf10 overexpression was described to cause
elongation of Meckel’s cartilage and enhanced chondrogenic
differentiation within the mandible. Notably, proliferation of
mandibular cells was not affected by higher levels of FGF10, and
the longer Meckel’s cartilage was deformed and spiral-shaped,
which affected the final shape of the jaw (Terao et al., 2011).
The importance of FGF10 for proper mandibular development
is also supported by association between genetic polymorphisms
in FGF10 and mandibular prognathism in humans (Cruz et al.,
2017).
Salivary and Lacrimal Glands
As with its critical role during lung development, FGF10 plays
an important role in morphogenesis of branching organs within
the craniofacial complex, including the salivary and lacrimal
glands. The expression of Fgf10 is high in the mesenchyme
surrounding the developing salivary glands. Fgf10 null embryos
display aplasia of the salivary glands (Figure 2) with their
development arrested at the bud stage (Ohuchi et al., 2000;
Jaskoll et al., 2005). FGF10 acts upstream of SOX9 to positively
regulate the progenitor cell population and drive outgrowth of
the glands (Chatzeli et al., 2017). Furthermore, explant cultures of
salivary gland tissue can recapitulate the physiological branching
morphogenesis in vitro only if the epithelium is cultured with the
surrounding mesenchyme or if FGF10 is added to the culture
of the isolated epithelial tissue (Rebustini and Hoffman, 2009;
Knosp et al., 2012). Notably, regulation of binding affinity of
FGF10 to heparan sulfate is a decisive feature in the balance
between promoting gland morphogenesis fate toward branching
versus elongation (Patel et al., 2007; Makarenkova et al., 2009).
FGF10 dose-dependence during development of salivary glands
is further supported by the fact that mice heterozygous for Fgf10
have hypoplastic salivary glands and xerostomia (dry mouth)
(Jaskoll et al., 2005; May et al., 2015).
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The role of FGF10 in lacrimal gland development is similar
to its role in salivary gland morphogenesis. Fgf10, which is
expressed in the mesenchyme adjacent to developing lacrimal
epithelial bud, induces lacrimal gland development, and Fgf10
null murine embryos exhibit agenesis of all ocular glands –
the extraorbital and intraorbital lacrimal glands as well as the
Harderian gland (Govindarajan et al., 2000; Makarenkova et al.,
2000; Figure 3). The proteoglycans at the cell surface and in the
extracellular matrix also affect lacrimal gland morphogenesis –
the O-sulfation of heparan sulfate was shown to be essential for
FGF10–FGFR2 interaction on lacrimal gland cell surface (Qu
et al., 2011). In addition to the large orofacial glands, FGF10 also
plays an important role during development of nasal submucosal
glands responsible for mucus secretion in airways (May et al.,
2016).
Patients with ALSG (aplasia of the lacrimal and major
salivary glands) exhibit both salivary and lacrimal phenotypes,
and this rare disorder is caused by loss-of-function mutations
in FGF10 (Entesarian et al., 2007; Scheckenbach et al., 2008;
Seymen et al., 2017). ALSG patients suffer from xerostomia and
dental decay, eye irritation, and epiphora (excessive tearing).
In contrast, LADD syndrome covers a wider spectrum of
malformations, including the above mentioned dental and
auditory defects and also an abnormal number of fingers or
digits. Nevertheless, LADD syndrome overlaps with ALSG in
terms of lacrimal and salivary defects, and thus these two
autosomal dominant disorders are considered part of the
same phenotypic spectrum. The data from affected families
support this idea, with reports of a daughter with typical
features of LADD inheriting the mutation from her mother
with ALSG (Milunsky et al., 2006). Taken together, the
human clinical data confirm the importance of the correct
function and level of FGF10 in the development of craniofacial
structures, even though the precise regulation and severity
of the phenotype apparently depend on both genetic and
environmental factors. A systematically generated overview of
the phenotypes in Fgf10 null embryos is available at the
International Mouse Phenotype Consortium (IMPC) database:
www.mousephenotype.org.
SUMMARY AND DISCUSSION
FGF10 signaling plays important roles in the development of
many craniofacial structures. FGF10 is required for the branching
morphogenesis of salivary and lacrimal glands, for the closure of
the secondary palate, and for eyelid development; it also affects
the structure of the inner ear, taste papillae on the tongue, and
the shape of the teeth and skull. The craniofacial phenotypes
connected to FGF10 function along with known expression data
are summarized in Supplementary Table 1.
FGF10 is predominantly expressed in the mesenchyme of
developing structures and signals to adjacent epithelium. In
contrast to this classical epithelial–mesenchymal interaction,
structures of the inner ear exhibit strong epithelial expression
of both Fgf10 and Fgfr2 IIIb during development suggesting
dependence on paracrine signaling (Pirvola et al., 2000; Pauley
et al., 2003). Epithelial expression of Fgf10 within orofacial tissues
was described also in early oral epithelium (Kettunen et al., 2000).
Nevertheless, the conditional Fgf10 knock-out in neural crest
cells using Wnt1-Cre phenocopied the tooth as well as oral cavity
glands’ phenotype of the full knock-out and generally confirmed
that, in orofacial structures comprised of mesenchyme originated
fully from neural crest, the mesenchymal FGF10 plays the major
role (Teshima et al., 2016).
FGF10 exerts its function in development via diverse and
complex mechanisms. Perhaps the most widespread of these is
a direct or indirect influence on epithelial cell proliferation and
apoptosis, as in eyelid (Tao et al., 2005) or palate development
(Rice et al., 2004). Nevertheless, multiple other actions of FGF10,
such as regulation of migration or effect on adhesive behavior
of the oral epithelium, have also been described in these organs.
Control of proper morphogenesis and cell differentiation has also
been proposed as one of the roles of FGF10 in many organs, such
as salivary gland or inner ear (Alvarez et al., 2003; Makarenkova
et al., 2009).
The striking overlap between phenotypes of Fgf10 and Fgfr2
null mice explains why FGF10 is considered as the major ligand of
FGFR2 IIIb. Multiple FGFs can activate both FGFR2 IIIb (FGF3,
7, and 22 from the Fgf7 subfamily; but also FGF1) and FGFR2
IIIc (e.g., FGF1, 2, 4, 5, 6, 8, 9, or 16) (Zhang et al., 2006).
Nevertheless, the Fgf10 and Fgfr2 null mice share the majority
of defects within the orofacial area, with the exception of milder
tooth and inner ear defects in Fgf10 mutant mice (Kettunen et al.,
2000; Ohuchi et al., 2000; Pirvola et al., 2000), and development
of medial nasal glands, which are absent in Fgfr2 null mutants
but form normally in Fgf10 null mice (May et al., 2016). The
milder phenotypes in Fgf10 mutants are mostly explained by
compensation by FGF3 (Kettunen et al., 2000; Wright, 2003) or
FGF7 (May et al., 2016). Under certain conditions, FGF10 can
also likely bind to FGFR1.
Because of the perinatal lethality of Fgf10 null mutants, some
of the functions of FGF10 can be revealed only in conditional
knock-outs. Even the conditional approach is complicated by
the fact that many developmental events within the orofacial
area overlap both in timing and also in expression of similar
genes, so the choice of induction time and appropriate driver is
challenging, e.g., to avoid simultaneous cleft palate formation.
Other approaches such as genetic rescue by changing FGF10
dosage in particular mutants may be used and can bring valuable
information, but these must be interpreted with caution, as
can be seen for example in the case of the Apert syndrome
model.
The impact of absence or malfunction of FGF10 is apparent
not only from the animal model data but also from findings in
human patients. Thus, the FGF10 pathway presents a potential
pharmacological target for cure of rare diseases related to
overactivated or downregulated FGFR2 signaling. Also, this
knowledge lays the groundwork for potential medical treatment
to harness the regenerative potential of gland tissues, after
damage. A number of regenerative approaches are being
developed and tested in animal models (Lombaert et al., 2011;
Garg and Zhang, 2017; Emmerson et al., 2018). For example,
healthy lacrimal epithelial cell progenitor cultures (ECPCs) were
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isolated and cultured in the presence of FGF10 to achieve
budding and engraftment in injured lacrimal glands (Gromova
et al., 2017). In theory, engraftment of such cells taken
directly from cancer patients before radiotherapy could in the
future serve as a source of tissue regeneration. In general,
knowledge of the molecular cascades functioning during
physiological development provides a base for regenerative
approaches where FGF10 or its downstream targets can be
provided to cultured tissues to be used for engraftment.
In the future, perhaps FGF10 could be directly supplied
in situ, which could help patients with tissue damage or
patients with congenital diseases caused by aberrant FGF10
function.
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